IQSEC2 and epilepsy: Nevertheless, from this rough estimate, we could infer that IQSEC2-related encephalopathy is very likely to be highly underdiagnosed in our country if compared to the reported frequency of IQSEC2 pathogenic variants in 2% of all patients with ID and epilepsy who underwent a whole exome sequencing analysis [15].